SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MNA ARTICLE M impact

Cresco Labs closes PharmaCann acquisition for US$50 million

Cresco Labs announced the closing of its acquisition of 100% of PharmaCann Penn, LLC for aggregate consideration of US$50 million.

CL

Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) said it has closed its acquisition of 100% of the outstanding equity interests in PharmaCann Penn, LLC for aggregate consideration of US$50 million. The company described the deal as the Transaction.

Related stories